NCT04728971

To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
• Sex: All
• Age: 60 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the clinical success rate of micafungin in preventing invasive mycosis after liver transplantation.

Conditions

• Liver Transplantation

Interventions

Type	Name	Description
DRUG	Micafungin Sodium 50 MG Injection	Give Micafungin 150 mg/d within 24 hours after liver transplantation.
DRUG	Caspofungin Acetate	Give Caspofungin 35 mg/d lasts 1 week after liver transplantation.

Timeline

• Start date: 2022-10-01
• Primary completion: 2025-10-01
• Completion: 2026-02-01
• First posted: 2021-01-28
• Last updated: 2022-08-16